These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 20196954)
21. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Zhang Y; Zhao A; Wang X; Shi G; Jin H; Lin Q Fertil Steril; 2008 Nov; 90(5):1931-7. PubMed ID: 18023431 [TBL] [Abstract][Full Text] [Related]
22. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells. Keating SE; Zaiatz-Bittencourt V; Loftus RM; Keane C; Brennan K; Finlay DK; Gardiner CM J Immunol; 2016 Mar; 196(6):2552-60. PubMed ID: 26873994 [TBL] [Abstract][Full Text] [Related]
23. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection. Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913 [TBL] [Abstract][Full Text] [Related]
24. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels. Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448 [TBL] [Abstract][Full Text] [Related]
25. Increased number of CD16(+)CD56(dim) NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation. Tanaka J; Sugita J; Asanuma S; Arita K; Shono Y; Kikutchi M; Shiratori S; Wakasa K; Yasumoto A; Shigematu A; Kondo T; Kobayashi T; Asaka M; Imamura M Hum Immunol; 2009 Sep; 70(9):701-5. PubMed ID: 19524005 [TBL] [Abstract][Full Text] [Related]
26. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226 [TBL] [Abstract][Full Text] [Related]
27. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients. Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680 [TBL] [Abstract][Full Text] [Related]
28. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells. Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217 [TBL] [Abstract][Full Text] [Related]
29. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Huth TK; Staines D; Marshall-Gradisnik S J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723 [TBL] [Abstract][Full Text] [Related]
31. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells. Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754 [TBL] [Abstract][Full Text] [Related]
32. Effect of Transcatheter Arterial Chemoembolization Combined with Argon-Helium Cryosurgery System on the Changes of NK Cells and T Cell Subsets in Peripheral Blood of Hepatocellular Carcinoma Patients. Huang M; Wang X; Bin H Cell Biochem Biophys; 2015 Dec; 73(3):787-92. PubMed ID: 27259326 [TBL] [Abstract][Full Text] [Related]
33. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720 [TBL] [Abstract][Full Text] [Related]
34. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood]. Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283 [TBL] [Abstract][Full Text] [Related]
35. NK cell dysfunction with down-regulated CD16 and up-regulated CD56 molecules in patients with esophageal squamous cell carcinoma. Watanabe M; Kono K; Kawaguchi Y; Mizukami Y; Mimura K; Maruyama T; Izawa S; Fujii H Dis Esophagus; 2010 Nov; 23(8):675-81. PubMed ID: 20545975 [TBL] [Abstract][Full Text] [Related]
36. Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Wu Y; Kuang DM; Pan WD; Wan YL; Lao XM; Wang D; Li XF; Zheng L Hepatology; 2013 Mar; 57(3):1107-16. PubMed ID: 23225218 [TBL] [Abstract][Full Text] [Related]
37. Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alpha and ribavirin therapy. Lee S; Watson MW; Flexman JP; Cheng W; Hammond T; Price P J Med Virol; 2010 Apr; 82(4):568-74. PubMed ID: 20166183 [TBL] [Abstract][Full Text] [Related]
38. Human liver-resident CD56(bright)/CD16(neg) NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. Hudspeth K; Donadon M; Cimino M; Pontarini E; Tentorio P; Preti M; Hong M; Bertoletti A; Bicciato S; Invernizzi P; Lugli E; Torzilli G; Gershwin ME; Mavilio D J Autoimmun; 2016 Jan; 66():40-50. PubMed ID: 26330348 [TBL] [Abstract][Full Text] [Related]
39. IL-21 reinvigorates exhausted natural killer cells in patients with HBV-associated hepatocellular carcinoma in STAT1-depedent pathway. Jin Y; Sun Z; Geng J; Yang L; Song Z; Song H; Wang J; Tang J Int Immunopharmacol; 2019 May; 70():1-8. PubMed ID: 30780004 [TBL] [Abstract][Full Text] [Related]
40. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients. Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Soofi M Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):193-8. PubMed ID: 20404389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]